Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 123795
Published online Jan 14, 2027. doi: 10.3748/wjg.123795
Published online Jan 14, 2027. doi: 10.3748/wjg.123795
Figure 4 VEGFR-2 inhibition alleviated bile duct ligation-induced cirrhotic portal hypertension.
A: Construction of animal model of liver cirrhosis and AZD2171 administration; B: The portal hypertension hemodynamic parameters in rats from 4 groups; C: The histological staining of liver tissue sections using hematoxylin and eosin, Masson’s trichrome, and Sirius red. Immunohistochemical (IHC) staining of Collagen I and α-smooth muscle actin; in rat livers; D: Quantitative analysis of histopathological and IHC staining in C; E: Representative IHC images of CD68 in the mesentery; F: Quantitative analysis of CD68-positive cells; G: Representative IHC images of CD31 in the mesentery; H: Quantitative analysis of CD31 staining intensity. aP < 0.05. bP < 0.01. α-SMA: Α-smooth muscle actin; HE: Hematoxylin and eosin; BDL: Bile duct ligation.
- Citation: Wu GB, Luo GQ, Chen M, Cai KW, You XT, Han F, Zhang NZ, Luo M, Li Q, Huo HZ, Fan Q. Melatonin attenuates splanchnic hyperdynamic circulation in cirrhotic portal hypertension by disrupting POMK-VEGFR2 interaction. World J Gastroenterol 2027; 33(2): 123795
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/123795.htm
- DOI: https://dx.doi.org/10.3748/wjg.123795